Is the breast cancer risk associated with combined oral contraceptive pill (OCP) use sufficient to warrant a change in prescribing habits?
No. In Canada, the cumulative likelihood of breast cancer up to the age of 35 is very low – approximately two per 1,000 women. If the combined OCP-associated risk were 1.5-fold higher, combined OCP users would experience three breast cancer cases by age 35, rather than two per 1000 women in the general population.
Related Questions
- Is the breast cancer risk associated with combined oral contraceptive pill (OCP) use sufficient to warrant a change in prescribing habits?
- Who is at risk for venous thrombo-embolism (VTE) on the combined oral contraceptive pill (OCP)?
- Does the combined oral contraceptive pill (OCP) cause breast cancer?
